Egg consumption in relation to risk of cardiovascular disease and diabetes: a systematic review and meta-analysis123

https://doi.org/10.3945/ajcn.112.051318Get rights and content
Under an Elsevier user license
open archive

ABSTRACT

Background:

The associations of egg consumption with cardiovascular disease (CVD) and diabetes are still unclear.

Objective:

We aimed to quantitatively summarize the literature on egg consumption and risk of CVD, cardiac mortality, and type 2 diabetes by conducting a meta-analysis of prospective cohort studies.

Design:

A systematic literature review was conducted for published studies in PubMed and EMBASE through March 2012. Additional information was retrieved through Google or a hand review of the reference from relevant articles. Studies were included if they had a prospective study design, were published in English-language journals, and provided HRs and 95% CIs for the associations of interest. Data were independently extracted by 2 investigators, and the weighted HRs and 95% CIs for the associations of interest were estimated by using a random-effects model.

Results:

A total of 22 independent cohorts from 16 studies were identified, including participants ranging in number from 1600 to 90,735 and in follow-up time from 5.8 to 20.0 y. Comparison of the highest category (≥1 egg/d) of egg consumption with the lowest (<1 egg/wk or never) resulted in a pooled HR (95% CI) of 0.96 (0.88, 1.05) for overall CVD, 0.97 (0.86, 1.09) for ischemic heart disease, 0.93 (0.81, 1.07) for stroke, 0.98 (0.77, 1.24) for ischemic heart disease mortality, 0.92 (0.56, 1.50) for stroke mortality, and 1.42 (1.09, 1.86) for type 2 diabetes. Of the studies conducted in diabetic patients, the pooled HR (95% CI) was 1.69 (1.09, 2.62) for overall CVD.

Conclusions:

This meta-analysis suggests that egg consumption is not associated with the risk of CVD and cardiac mortality in the general population. However, egg consumption may be associated with an increased incidence of type 2 diabetes among the general population and CVD comorbidity among diabetic patients.

Cited by (0)

1

From the Departments of Nutrition and Epidemiology, Gillings Schools of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (JYS, PX, and KH); the Department of Internal Medicine, Yonsei University, Wonju College of Medicine, Wonju, Republic of Korea (JYS); the Department of Epidemiology and Biostatistics, School of Public Health, Indiana University, Bloomington, IN (PX and KH); and Cardiovascular Epidemiology, Kyoto Women’s University, Kyoto, Japan (YN).

2

Supported in part by grants from the NIH (R21NS056445 and R21DK073812). JYS was supported in part by a visiting scholar grant from Yonsei University, Wonju College of Medicine, Wonju, Republic of Korea.

3

Address correspondence to K He, Department of Epidemiology and Biostatistics, School of Public Health, Indiana University, 1025 E Seventh Street, C034, Bloomington, IN 47405. E-mail: [email protected].

4

Abbreviations used: CHD, coronary heart disease; CVD, cardiovascular disease; IHD, ischemic heart disease; RCT, randomized controlled trial.